Cumulative exposure to high-dose angiotensin receptor blockers was associated with excess risk for cancer, according to a meta-regression analysis published in PLOS One.“About 200 million people ...

Though the renal protection provided by antihypertensive doses of ACE inhibitors and ARBs has been extensively studied, the dose response of these agents may be different for renal protection.

FDA officials announced Thursday that the agency's meta-analysis study did not find a correlation between the commonly prescribed class of blood pressure drugs called angiotensin receptor blockers ...

It comprised 74,021 patients assigned an ARB (for a total cumulative exposure of 172,389 person-years of exposure to daily high dose) and 61,197 patients randomized to control.

However, at doses achieving the same blood pressure, RAAS inhibitors, such as angiotensin-converting-enzyme (ACE) inhibitors and ARBs, reduce proteinuria further than non-RAAS-inhibiting drugs, an ...

Nov. 19 -- TUESDAY, Nov. 17 (HealthDay News) -- For people with heart failure, high doses of the drug losartan, an angiotensin-receptor blocker (ARB), reduce the risk for hospital admission and ...

Chicago, IL - Two new studies presented this week at the American Society of Hypertension 2007 Scientific Sessions suggest that fixed-dose combination therapy with the calcium-channel blocker ...

The mean (±SD) rate of change in aortic-root diameter decreased significantly from 3.54±2.87 mm per year during previous medical therapy to 0.46±0.62 mm per year during ARB therapy (P<0.001).

At 30 weeks, even diabetics had a 33% reduction, researchers report. LONDON, Ont.—High doses of the angiotensin receptor blocker (ARB) candesartan reduce proteinuria by one third, even in people ...

Treatment users were stratified into 4 subgroups according to cumulative ARB defined daily doses (DDD) of 91 to 180, 181 to 360, 361 to 720, and more than 720, and then these users were compared ...

Infectious Disease > COVID-19 Don't Try ARBs for Severe COVID, Trial Indicates — Harms seen without any compensating survival benefit. by Katherine Kahn, Staff Writer, MedPage Today July 12 ...